These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3932513)

  • 21. The early effects of valproic acid in low doses in liver metabolism.
    Culebras M; Doval M; Rengel M; López-Novoa JM
    Rev Esp Fisiol; 1989 Dec; 45(4):327-30. PubMed ID: 2517150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valproic acid metabolites inhibit dihydrolipoyl dehydrogenase activity leading to impaired 2-oxoglutarate-driven oxidative phosphorylation.
    Luís PB; Ruiter JP; Aires CC; Soveral G; de Almeida IT; Duran M; Wanders RJ; Silva MF
    Biochim Biophys Acta; 2007 Sep; 1767(9):1126-33. PubMed ID: 17706936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valproic acid glucuronidation is associated with increases in 15-F2t-isoprostane in rats.
    Tong V; Teng XW; Karagiozov S; Chang TK; Abbott FS
    Free Radic Biol Med; 2005 Jun; 38(11):1471-83. PubMed ID: 15890621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum and liver tissue biotinidase enzyme activity in rats which were administrated to valproic acid.
    Korkmazer N; Vurucu S; Demirkaya E; Unay B; Kul M; Akin R; Gokcay E
    Brain Dev; 2006 Sep; 28(8):515-20. PubMed ID: 16682156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The disposition of valpromide in rats and the isolated perfused rat liver.
    Billig H; Ziv E; Bar-On H; Bialer M
    Drug Metab Dispos; 1990; 18(2):238-44. PubMed ID: 1971580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valproic acid I: time course of lipid peroxidation biomarkers, liver toxicity, and valproic acid metabolite levels in rats.
    Tong V; Teng XW; Chang TK; Abbott FS
    Toxicol Sci; 2005 Aug; 86(2):427-35. PubMed ID: 15858223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valproate ameliorates thioacetamide-induced fibrosis by hepatic stellate cell inactivation.
    Aher JS; Khan S; Jain S; Tikoo K; Jena G
    Hum Exp Toxicol; 2015 Jan; 34(1):44-55. PubMed ID: 24812151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary changes in liver damage by aspirin in rats.
    Tomoda T; Kurashige T; Hayashi Y; Enzan H
    Acta Paediatr Jpn; 1998 Dec; 40(6):593-6. PubMed ID: 9893296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unaltered hepatic oxidative phosphorylation and mitochondrial permeability transition in wistar rats treated with nimesulide: Relevance for nimesulide toxicity characterization.
    Moreno AJ; Oliveira PJ; Nova CD; Alvaro AR; Moreira RA; Santos SM; Macedo T
    J Biochem Mol Toxicol; 2007; 21(2):53-61. PubMed ID: 17427176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of valproic acid on zinc metabolism in the rat.
    Daffron JC; Kasarskis EJ
    Toxicol Lett; 1984 Dec; 23(3):321-5. PubMed ID: 6441315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [An experimental study on hepatotoxicity of topiramate in young rats].
    Huang J; Ren RN; Chen XM; Ye LY
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):54-8. PubMed ID: 17306079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the role of in situ generated (E)-2,4-diene-valproic acid in the toxicity of valproic acid and (E)-2-ene-valproic acid in sandwich-cultured rat hepatocytes.
    Surendradoss J; Chang TK; Abbott FS
    Toxicol Appl Pharmacol; 2012 Nov; 264(3):413-22. PubMed ID: 22940460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The hepatotoxicity of valproic acid and its metabolites in rats. II. Intermediary and valproic acid metabolism.
    Granneman GR; Wang SI; Kesterson JW; Machinist JM
    Hepatology; 1984; 4(6):1153-8. PubMed ID: 6437961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the beta-oxidation of valproic acid in rat liver mitochondrial preparations.
    Bjorge SM; Baillie TA
    Drug Metab Dispos; 1991; 19(4):823-9. PubMed ID: 1680661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased conversion of tryptophan to nicotinamide in rats by dietary valproate.
    Shibata K; Kondo R; Sano M; Fukuwatari T
    Biosci Biotechnol Biochem; 2013; 77(2):295-300. PubMed ID: 23391917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver.
    Martins NM; Santos NA; Curti C; Bianchi ML; Santos AC
    J Appl Toxicol; 2008 Apr; 28(3):337-44. PubMed ID: 17604343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subchronic effects of valproic acid on gene expression profiles for lipid metabolism in mouse liver.
    Lee MH; Kim M; Lee BH; Kim JH; Kang KS; Kim HL; Yoon BI; Chung H; Kong G; Lee MO
    Toxicol Appl Pharmacol; 2008 Feb; 226(3):271-84. PubMed ID: 17963808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition by valproic acid of pyruvate uptake by brain mitochondria.
    Benavides J; Martin A; Ugarte M; Valdivieso F
    Biochem Pharmacol; 1982 Apr; 31(8):1633-6. PubMed ID: 6807323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of methyluracil on oxidative phosphorylation in the hepatic mitochondria of rats poisoned with dichloroethane.
    Natsyuk MV; Fedurov VV
    Bull Exp Biol Med; 1974 Oct; 77(4):391-3. PubMed ID: 4425740
    [No Abstract]   [Full Text] [Related]  

  • 40. Carnitine metabolism and morphometric change of liver mitochondria in valproate-treated rats.
    Murakami K; Sugimoto T; Nishida N; Woo M; Araki A; Kobayashi Y; Sakane Y
    Neuropediatrics; 1990 Nov; 21(4):187-90. PubMed ID: 2290478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.